Return to: Medical School : Academic Health Center : myAHC : U of M Home

Gold University of Minnesota M. Skip to main content. Link to University of Minnesota homepage
IPTR masthead graphic
Whats Inside
Contact Us

About Us

Registry Staff

Annual Reports

IPTR Database

IPTR Links

Slide Library

 

IPTR Home

Home > Annual Reports > 2003 Annual Report > Effect of Venous Vascular Management on USA ED Pancreas Outcome 1999 - 2003 Cases

Printer-friendly version   Mail this page to a friend

Effect of Venous Vascular Management on USA ED Pancreas Outcome 1999 - 2003 Cases


For primary DD pancreas transplants during 1999-2003, 78% SPK, 60% PAK, 49% PTA were enteric drained (ED). Of cases with complete records for analysis of systemic (SV) and portal (PV) venous vascular management (n=3635), about 25% used PV (n=920) vs. SV (n=2715).  Pancreas graft survival rates were similar for SPK (p>0.17) and PAK (p>0.8) PV vs. SV ED transplants: 1-year SPK 87% PV and 84% SV, 3-year 77% each (Figure 16a); 1-year PAK 74% PV and 77% SV, 3-year 53% and 54% respectively (Figure 16b). For ED PTA, pancreas PV (n=90) GSRs were higher than SV (n=99), but not significantly (p>0.11): 1-year 80% PV and 69% SV, 3-year 69% and 34% respectively (Figure 16c). Rejection loss accounted for this difference in the PTA ED GSRs. Even though there may be an immunological advantage with ED in PTA, the rejection rate is higher, possibly due to more prompt diagnosis of rejection episodes using urine amylase monitoring in BD cases (Figure 16d). 

SPK Pancreas Graft Survival by Vasc Management
Figure 16a

PAK Pancreas Graft Survival by Vasc Management
Figure 16b

PTA Pancreas Graft Survival by Vasc Management
Figure 16c

PTA Immunological Graft Loss by Vasc Management
Figure 16d

Previous page / Next page / Index


Feedback | Notice of Privacy Practices

 
The University of Minnesota is an equal opportunity educator and employer.